Assessment of analgesic utilization and quality of life in cancer patients: A cross-sectional survey
Abstract
Background: To date, limited data exist on analgesic utilization and its association with quality of life (QoL) among oncology patients. This study aims to assess the association between pain, analgesic use, and QoL of cancer patients. Methods: A descriptive cross-sectional survey was conducted among 408 cancer patients attending the outpatient oncology clinic at Lagos University Teaching Hospital. Sociodemographic data, types of cancer, types of treatment, analgesic utilization, description, and severity of pain were obtained using a well-structured self-designed proforma. QoL was assessed using the WHOQoL-BREF questionnaire. Regression analysis estimated the association between pain and QoL in an unadjusted/adjusted analysis. Results: The most common cancer in the female and male populations was breast cancer (51.7%, n = 218) and prostate cancer (5.9%, n = 25), respectively. The prevalence of analgesic utilization was 89.9%. The majority (70.1%, n = 286) of the participants had moderate-to-severe pain scores. Fifty-eight percent (n = 236) of participants had satisfactory health. QoL was rated as poor/very poor in 17% (n = 68). Compared to cancer patients with no to mild pain, those with moderate-to-severe pain had poorer QoL (odds ratio [OR] =0.12, 95% confidence interval [CI]: 0.04, 0.33). This relationship remained significant after adjusting for other covariates, including analgesic use (OR = 0.10, 95% CI: 0.03–0.29). Conclusion: A high prevalence of moderate to severe pain was observed among cancer patients, negatively affecting their QoL. Interestingly, this association was independent of analgesic use, suggesting that other pain management strategies are warranted to improve QoL.
Related
- Assessment of Health-Related Quality of Life in Gastric Cancer Patients: A Cross-Sectional Study in North-Eastern Kazakhstan.
- Epidemiological Study of Utilization of National Tuberculosis Elimination Programme Services among Key TB Patients accessing Public Sector Facilities in Central Gujarat: A Cross-Sectional Study
- Assessment of quality of life among professional palliative care providers in Tabuk City, Saudi Arabia : A cross-sectional study
- Assessment of the appropriateness of the selection for radiotherapy intensity from a quality of life (EORTC QLQ-C30) perspective in older patients with cancer
- Associations between early antidepressant exposure, affective states, and subjective sleep quality among euthymic depressive-onset bipolar patients: a cross-sectional parallel mediation analysis
BibTeX
@article{busari2026assessment,
title = {{Assessment of analgesic utilization and quality of life in cancer patients: A cross-sectional survey}},
author = {Abdulwasiu Adeniyi Busari and Ifedolapo Adesola Adejumo and Sikiru Olatunji Usman and Oludaisi Adesina Oduniyi and Saliu Adejumobi Balogun and Kazeem Adeola Oshikoya and Sunday Oluwafemi Olayemi},
journal = {Journal of Clinical Sciences},
year = {2026},
month = jul,
doi = {10.4103/jcls.jcls_206_25},
url = {https://doi.org/10.4103/jcls.jcls_206_25},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - Assessment of analgesic utilization and quality of life in cancer patients: A cross-sectional survey
AU - Abdulwasiu Adeniyi Busari
AU - Ifedolapo Adesola Adejumo
AU - Sikiru Olatunji Usman
AU - Oludaisi Adesina Oduniyi
AU - Saliu Adejumobi Balogun
AU - Kazeem Adeola Oshikoya
AU - Sunday Oluwafemi Olayemi
PY - 2026
DA - 2026/07/01
JO - Journal of Clinical Sciences
DO - 10.4103/jcls.jcls_206_25
UR - https://doi.org/10.4103/jcls.jcls_206_25
AB - Background: To date, limited data exist on analgesic utilization and its association with quality of life (QoL) among oncology patients. This study aims to assess the association between pain, analgesic use, and QoL of cancer patients. Methods: A descriptive cross-sectional survey was conducted among 408 cancer patients attending the outpatient oncology clinic at Lagos University Teaching Hospital. Sociodemographic data, types of cancer, types of treatment, analgesic utilization, description, and severity of pain were obtained using a well-structured self-designed proforma. QoL was assessed using the WHOQoL-BREF questionnaire. Regression analysis estimated the association between pain and QoL in an unadjusted/adjusted analysis. Results: The most common cancer in the female and male populations was breast cancer (51.7%, n = 218) and prostate cancer (5.9%, n = 25), respectively. The prevalence of analgesic utilization was 89.9%. The majority (70.1%, n = 286) of the participants had moderate-to-severe pain scores. Fifty-eight percent (n = 236) of participants had satisfactory health. QoL was rated as poor/very poor in 17% (n = 68). Compared to cancer patients with no to mild pain, those with moderate-to-severe pain had poorer QoL (odds ratio [OR] =0.12, 95% confidence interval [CI]: 0.04, 0.33). This relationship remained significant after adjusting for other covariates, including analgesic use (OR = 0.10, 95% CI: 0.03–0.29). Conclusion: A high prevalence of moderate to severe pain was observed among cancer patients, negatively affecting their QoL. Interestingly, this association was independent of analgesic use, suggesting that other pain management strategies are warranted to improve QoL.
SN - 2468-6859
SN - 2408-7408
ER -